|
DYNC1H1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.58890000000667E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.361700E-02 |
| Normal-vs-Stage2 |
1.67218999999053E-05 |
| Normal-vs-Stage3 |
7.07930003507329E-09 |
| Normal-vs-Stage4 |
2.22919999999238E-05 |
| Stage1-vs-Stage2 |
4.779000E-03 |
| Stage1-vs-Stage3 |
2.24849999996835E-06 |
| Stage1-vs-Stage4 |
3.662300E-03 |
| Stage2-vs-Stage3 |
7.670600E-01 |
| Stage2-vs-Stage4 |
8.047000E-01 |
| Stage3-vs-Stage4 |
5.476000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62320000000049E-05 |
| Normal-vs-AfricanAmerican |
7.476300E-02 |
| Normal-vs-Asian |
8.630000E-01 |
| Caucasian-vs-AfricanAmerican |
1.095180E-01 |
| Caucasian-vs-Asian |
1.626350E-01 |
| AfricanAmerican-vs-Asian |
5.161600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.94470000003388E-06 |
| Normal-vs-Female |
4.519000E-03 |
| Male-vs-Female |
3.095800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.027380E-01 |
| Normal-vs-Age(41-60Yrs) |
2.636900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.51429999994956E-06 |
| Normal-vs-Age(81-100Yrs) |
5.68249999999271E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.108000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.275800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.453800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.931900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.555800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.232250E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.759800E-02 |
| Normal-vs-Grade 2 |
4.142100E-03 |
| Normal-vs-Grade 3 |
7.80269999944849E-07 |
| Normal-vs-Grade 4 |
4.10559999997062E-07 |
| Grade 1-vs-Grade 2 |
2.659100E-03 |
| Grade 1-vs-Grade 3 |
3.73940000000239E-05 |
| Grade 1-vs-Grade 4 |
3.61360000000754E-06 |
| Grade 2-vs-Grade 3 |
1.186090E-02 |
| Grade 2-vs-Grade 4 |
3.756300E-03 |
| Grade 3-vs-Grade 4 |
2.422000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.461500E-03 |
| Normal-vs-ccB subtype |
3.81259999999717E-05 |
| ccA subtype-vs-ccB subtype |
5.912400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.68659999999688E-05 |
| Normal-vs-N1 |
5.323100E-03 |
| N0-vs-N1 |
4.567200E-01 |
|
|
